These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20671295)

  • 1. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.
    Lile JA; Babalonis S; Emurian C; Martin CA; Wermeling DP; Kelly TH
    J Clin Pharmacol; 2011 Jun; 51(6):888-98. PubMed ID: 20671295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
    Stoops WW; Vansickel AR; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users.
    Reed SC; Evans SM
    Drug Alcohol Depend; 2016 Jun; 163():141-52. PubMed ID: 27114203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
    Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
    Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar discriminative-stimulus effects of D-amphetamine in women and men.
    Vansickel AR; Lile JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.
    Jasinski DR; Krishnan S
    J Psychopharmacol; 2009 Jun; 23(4):419-27. PubMed ID: 19329547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
    Sevak RJ; Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):220-7. PubMed ID: 20560842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human sex differences in d-amphetamine self-administration.
    Vansickel AR; Stoops WW; Rush CR
    Addiction; 2010 Apr; 105(4):727-31. PubMed ID: 20148783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of impulsivity with amphetamine in an appetitive fixed consecutive number schedule with cue for optimal performance in rats.
    Rivalan M; Grégoire S; Dellu-Hagedorn F
    Psychopharmacology (Berl); 2007 Jun; 192(2):171-82. PubMed ID: 17265075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
    Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
    Hamidovic A; Dlugos A; Skol A; Palmer AA; de Wit H
    Exp Clin Psychopharmacol; 2009 Dec; 17(6):374-83. PubMed ID: 19968402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.